Synthesis of spirocyclic C-arylglycosides and -ribosides by ruthenium-catalyzed cycloaddition

Chemistry - An Asian Journal

Volumn 2, Issue 11, 2007, Pages 1388-1399

  Yamamoto, Yoshihiko ^a   Yamashita, Ken ^a   Hotta, Tomitaka ^a   Hashimoto, Toru ^b   Kikuchi, Makoto ^b   Nishiyama, Hisao ^b  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Copper; Cycloaddition; Glycosides; Palladium ruthenium

Indexed keywords

DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; GLYCOSIDE; RUTHENIUM;

ARTICLE; CATALYSIS; CHEMISTRY; CYCLIZATION; SYNTHESIS;

CATALYSIS; CYCLIZATION; GLYCOSIDES; INDICATORS AND REAGENTS; RUTHENIUM;

EID: 35948972070     PISSN: 18614728     EISSN: 1861471X     Source Type: Journal    
DOI: 10.1002/asia.200700077     Document Type: Article

References (114)

1. a) J. Rohr, R. Thiericke, Nat. Prod. Rep. 1992, 9, 103-137;
2. b) M. C. Carreño, A. Urbano, Synlett 2005, 1-25;
3. c) T. Bililign, B. R. Griffith, J. S. Thorson, Nat. Prod. Rep. 2005, 22, 742-760.
4. K. Suzuki, Pure Appl. Chem. 1994, 66, 2175-2178.
5. a) K. A. Parker, Y.-h. Koh, J. Am. Chem. Soc. 1994, 116, 11149-11150;
6. b) K. A. Parker, Pure Appl. Chem. 1994, 66, 2135-2138.
7. a) D. E. Kaelin, Jr., O. D. Lopez, S. F. Martin, J. Am. Chem. Soc. 2001, 123, 6937-6938;
8. b) B. Apsel, J. A. Bender, M. Escobar, D. E. Kaelin, Jr., O. D. Lopez, S. E Martin, Tetrahedron Lett. 2003, 44, 1075-1077;
9. c) D. E. Kaelin, Jr., S. M. Sparks, H. R. Plake, S. F. Martin, J. Am. Chem. Soc. 2003, 125, 12994-12995;
10. d) C.-L. Chen, S. M. Sprks, S. F. Martin, J. Am. Chem. Soc. 2006, 128, 13696-13697.
11. For reviews, see: a) G. D. Daves, Jr., Acc. Chem. Res. 1990, 23, 201-206;
12. b) M. H. Postema, Tetrahedron 1992, 48, 8545-8599;
13. c) Y. Du, R. J. Linhardt, I. R. Vlahov, Tetrahedron 1998, 54, 9913-9959;
14. d) H. Togo, W. He, Y. Waki, M. Yokoyama, Synlett 1998, 700-717;
15. e) M. Isobe, R. Nishizawa, S. Hosokawa, T. Nishikawa, Chem. Commun. 1998, 2665-2676;
16. f) I. P. Smoliakova, Curr. Org. Chem. 2000, 4, 589-608;
17. g) L. Somsák, Chem. Rev. 2001, 101, 81-135;
18. h) C. Taillefumier, Y. Chapleur, Chem. Rev. 2004, 104, 263-292;
19. i) W. Zou, Curr. Top. Med. Chem. 2005, 5, 1363-1391;
20. j) R. Saeeng, M. Isobe, Chem. Lett. 2006, 35, 552-557.
21. For recent examples of the synthesis of spiroacetal units relevant to papulacandins, see: a) M. M. Ahmed, G. A. O'Doherty, Tetrahedron Lett. 2005, 46, 4151-4155;
22. b) D. Balachari, G. A. O'Doherty, Org. Lett. 2000, 2, 4033-4036;
23. c) D. Balachari, G. A. O'Doherty, Org. Lett. 2000, 2, 863-866;
24. d) M. A. Brimble, V. Caprio, A. D. Johnston, M. Sidford, Synthesis 2001, 855-862;
25. e) K. A. Parker, A. T. Georges, Org. Lett. 2000, 2, 497-499; total synthesis of papulacandin D:
26. f) A. G. M. Barrett, M. Peña, J. A. Willardsen, J. Org. Chem. 1996, 61, 1082-1100;
27. g) S. E. Denmark, C. S. Regens, T. Kobayashi, J. Am. Chem. Soc. 2007, 129, 2774-2776.
28. a) D. M. Schmatz, M. A. Romancheck, L. A. Pittarelli, R. E. Schwartz, R. A. Fromtling, K. H. Nollstadt, F. L. Vanmiddlesworth, K. E. Wilson, M. J. Turner, Proc. Natl. Acad. Sci. USA 1990, 87, 5950-5954;
29. b) M. Debono, R. S. Gordee, Annu. Rev. Microbiol. 1994, 48, 471-497.
30. a) C. Jaramillo, S. Knapp, Synthesis 1994, 1-20;
31. b) D. Y. W. Lee, M. He, Curr. Top. Med. Chem. 2005, 5, 1333-1350.
32. a) R. R. Schmidt, G. Effenberger, Liebigs Ann. Chem. 1987, 825-831;
33. b) S. R. Pulley, J. P. Carey, J. Org. Chem. 1998, 63, 5275-5279;
34. c) D. Paetsch, K. H. Dötz, Tetrahedron Lett. 1999, 40, 487-488;
35. d) E. Janes, M. Nieger, P. Saarenketo, K. H. Dötz, Eur. J. Org. Chem. 2003, 2276-2285;
36. e) C. Fuganti, S. Serra, Synlett 1999, 1241-1242;
37. f) E. Brenna, C. Fuganti, P. Grasselli, S. Serra, S. Zambotti, Chem. Eur. J. 2002, 8, 1872-1878;
38. g) K. P. Kaliappan, A. V. Subrahmanyam, Org. Lett. 2007, 9, 1121-1124.
39. a) F. E. McDonald, H. Y. H. Zhu, C. R. Holmquist, J. Am. Chem. Soc. 1995, 117, 6605-6606;
40. b) Y. Yamamoto, T. Saigoku, T. Ohgai, H. Nishiyama, K. Itoh, Chem. Commun. 2004, 2702-2703;
41. c) Y. Yamamoto, T. Saigoku, H. Nishiyama, T. Ohgai, K. Itoh, Org. Biomol. Chem. 2005, 3, 1768-1775;
42. d) P. Novák, R. Pohl, M. Kotora, M. Hocek, Org. Lett. 2006, 8, 2051-2054.
43. A part of this study was reported as a preliminary communication: Y. Yamamoto, T. Hashimoto, K. Hattori, M. Kikuchi, H. Nishiyama, Org. Lett. 2006, 8, 3565-3568.
44. a) P. A. Wender, B. L. Miller in Organic Synthesis: Theory and Applications, Vol. 2 (Ed.: T. Hudlicky), JAI, Greenwich, 1993, pp. 27-66;
45. b) P. A. Wender, S. Handy, D. L. Wright, Chem. Ind. (London) 1997, 765-769.
46. a) K. Tomooka, H. Yamamoto, T. Nakai, J. Am. Chem. Soc. 1996, 118, 3317-3318; see also:
47. b) B. M. Trost, E. D. Edstrom, Angew. Chem. 1990, 102, 541-543;
48. Angew. Chem. Int. Ed. Engl. 1990, 29, 520-522;
49. c) K. Tomooka, Y. Nakamura, T. Nakai, Synlett 1995, 321-322;
50. d) P. A. V. van Hooft, M. A. Leeuwenburgh, H. S. Overkleeft, G. A. van der Marel, C. A. A. van Boeckelvan, J. H. Boom, Tetrahedron Lett. 1998, 39, 6061-6064;
51. e) M. A. Leeuwenburgh, C. C. M. Appeldoorn, P. A. V. van Hooft, H. S. Overkleeft, G. A. van der Marel, J. H. van Boom, Eur. J. Org. Chem. 2000, 873-877.
52. For Cp*RuCl-catalyzed selective alkyne cyclotrimerizations, see: a) Y. Yamamoto, R. Ogawa, K. Itoh, Chem. Commun. 2000, 549-550;
53. b) Y. Yamamoto, K. Hata, T. Arakawa, K. Itoh, Chem. Commun. 2003, 1290-1291;
54. c) Y. Yamamoto, T. Arakawa, R. Ogawa, K. Itoh, J. Am. Chem. Soc. 2003, 125, 12143-12160;
55. d) Y. Yamamoto, K. Kinpara, T. Saigoku, H. Nishiyama, K. Itoh, Org. Biomol Chem. 2004, 2, 1287-1294;
56. e) Y. Yamamoto, J. Ishii, H. Nishiyama, K. Itoh, J. Am. Chem. Soc. 2004, 126, 3712-3713;
57. f) Y. Yamamoto, J. Ishii, H. Nishiyama, K. Itoh, J. Am. Chem. Soc. 2005, 127, 9625-9631;
58. g) Y. Yamamoto, J. Ishii, H. Nishiyama, K. Itoh, Tetrahedron 2005, 61, 11501-11510.
59. a) Y. Yamamoto, K. Kinpara, H. Nishiyama, K. Itoh, Adv. Synth. Catal. 2005, 347, 1913-1916;
60. b) Y. Yamamoto, K. Kinpara, R. Ogawa, H. Nishiyama, K. Itoh, Chem. Eur. J. 2006, 12, 5618-5631;
61. c) Y. Yamamoto, K. Kinpara, T. Saigoku, H. Takagishi, S. Okuda, H. Nishiyama, K. Itoh, J. Am. Chem. Soc. 2005, 127, 605-613.
62. a) E. T. Kool, Acc. Chem. Res. 2002, 35, 936-943;
63. b) Q. Wu, C. Simons, Synthesis 2004, 1533-1553.
64. a) M. Ishikawa, I. Hirao, S. Yokoyama, Tetrahedron Lett. 2000, 41, 3931-3934;
65. b) T. Fujiwara, M. Kimoto, H. Sugiyama, I. Hirao, S. Yokoyama, Bioorg. Med. Chem. Lett. 2001, 11, 2221-2223; see also:
66. c) Z. Sun, S. Ahmed, L. W. McLaughlin, J. Org. Chem. 2006, 71, 2922-2925.
67. a) S. L. Schreiber, Science 2000, 287, 1964-1969;
68. b) M. D. Burke, S. L. Schreiber, D. R. Spring, Org. Biomol. Chem. 2003, 1, 3867-3870.
69. Y. Yamamoto, K. Hattori, H. Nishiyama, J. Am. Chem. Soc. 2006, 128, 8336-8340.
70. For a related approach to C-biaryldeoxyribosides, see: M. Hocek, R. Pohl, B. Klepetářová, Eur. J. Org. Chem. 2005, 4525-4528.
71. H. Hofmeister, K. Annen, H. Laurent, R. Wiechert, Angew. Chem. 1984, 96, 720-722;
72. Angew. Chem. Int. Ed. Engl. 1984, 23, 727-729.
73. S. D. Walker, T. E. Barder, J. R. Martinelli, S. L. Buchwald, Angew. Chem. 2004, 116, 1907-1912;
74. Angew. Chem. Int. Ed. 2004, 43, 1871-1876.
75. T. Nishikawa, S. Shibuya, S. Hosokawa, M. Isobe, Synlett 1994, 485-486.
76. a) A. Dondoni, A. Marra, Chem. Rev. 2000, 100, 4395-4421;
77. b) A. Dondoni, A. Massi, Acc. Chem. Res. 2006, 39, 451-463;
78. c) E. von Moos, R. N. Ben, Curr. Top. Med. Chem. 2005, 5, 1351-1361.
79. S. Kotha, Acc. Chem. Res. 2003, 36, 342-351.
80. a) S. Manabe, Y. Ito, T. Ogawa, Chem. Lett. 1998, 919-920;
81. b) S. Manabe, Y. Ito, J. Am. Chem. Soc. 1999, 121, 9754-9755;
82. c) S. Manabe, Y. Marui, Y. Ito, Chem. Eur. J. 2003, 9, 1435-1447;
83. d) T. Nishikawa, M. Ishikawa, M. Isobe, Synlett 1999, 123-125;
84. e) T. Nishikawa, M. Ishikawa, K. Wada, M. Isobe, Synlett 2001, 945-947;
85. f) T. Nishikawa, Y. Koide, S. Kajii, K. Wada, M. Ishikawa, M. Isobe, Org. Biomol. Chem. 2005, 3, 687-700;
86. g) T. Nishikawa, Y. Koide, A. Kanakubo, H. Yoshimura, M. Isobe, Org. Biomol. Chem. 2006, 4, 1268-1277.
87. a) P. Čapek, R. Pohl, M. Hocek, J. Org. Chem. 2005, 70, 8001-8008;
88. b) P. Čapek, M. Hocek, Synlett 2005, 3005-3007;
89. c) P. Čapek, R. Pohl, M. Hocek, Org. Biomol. Chem. 2006, 4, 2278-2284.
90. For examples, see: a) K. C. Nicolaou, S. A. Snyder, Classics in Total Synthesis II, Wiley-VCH, Weinheim, 2003, pp. 237-300;
91. b) E. Moreno, L. A. Nolasco, L. Caggiano, R. F. W. Jackson, Org. Biomol. Chem. 2006, 4, 3639-3647.
92. a) P. C. Srivastava, D. G. Streeter, T. R. Matthews, L. B. Allen, R. W. Sidwell, R. K. Robins, J. Med. Chem. 1976, 19, 1020-1026;
93. b) N. Minakawa, T. Takeda, T. Sasaki, A. Matsuda, T. Ueda, J. Med. Chem. 1991, 34, 778-786;
94. c) A. M. Almerico, A. Lauria, P. Diana, P. Barraja, G. Cirrincione, G. Dattolo, ARKIVOC 2000, 486-496; D. L. Barnard, C. W. Day, K. Bailey, M. Heiner, R. Montgomery, L. Lauridsen, S. Winslow, J. Hoopes, J. K.-K. Li, J. Lee, D. A. Carson, H. B. Cottam, R. W. Sidwell, Antiviral Res. 2006, 71, 53-63, and references cited therein.
95. a) G. R. Greenberg, J. Am. Chem. Soc. 1952, 74, 6307-6308;
96. b) E. D. Korn, F. C. Charalampous, J. M. Buchanan, J. Am. Chem. Soc. 1953, 75, 3610-3611;
97. c) G. R. Greenberg, E. L. Spilman, J. Biol. Chem. 1956, 219, 411-422.
98. K. Mizuno, M. Tsujino, M. Takada, M. Hayashi, K. Atsumi, K. Asano, T. Matsuda, J. Antibiot. 1974, 27, 775-782.
99. a) R. S. Coleman, Y. Dong, J. C. Arthur, Tetrahedron Lett. 1993, 34, 6867-6870;
100. b) B. A. Schweitzer, E. T. Kool, J. Org. Chem. 1994, 59, 7238-7242;
101. C. L. Chepanoske, C. R. Langelier, N. H. Chemiel, S. S. David, Org. Lett. 2000, 2, 1341-1344.
102. J. D. Williams, J. J. Chen, J. C. Drach, L. B. Townsend, J. Med. Chem. 2004, 47, 5766-5772.
103. For an excellent review of copper-mediated C(aryl)-heteroatom bond formations, see: S. V. Ley, A. W. Thomas, Angew. Chem. 2003, 115, 5558-5607;
104. Angew. Chem. Int. Ed. 2003, 42, 5400-5449.
105. J. C. Antilla, A. Klapars, S. L. Buchwald, J. Am. Chem. Soc. 2002, 124, 11684-11688.
106. The refinement of the structure could not be completed due to the disordered solvated molecules, but the gross structure of 35 was established.
107. N. Oshima, H. Suzuki, Y. Moro-oka, Chem. Lett. 1984, 1161-1164.
108. a) P. Moeller, Justus Liebigs Ann. Chem. 1972, 755, 191-193;
109. b) A. Borbás, G. Szabovik, Z. Antal, K. Fehér, M. Gsávás, L. Szilágyi, P. Herczegh, A. Lipták, Tetrahedron: Asymmetry 2000, 11, 549-566.
110. N. E. Batoux, F. Paradisi, P. C. Engel, M. E. Migaud, Tetrahedron 2004, 60, 6609-6617.
111. a) F. Firooznia, C. Gude, K. Chan, N. Marcopulos, Y. Satoh, Tetrahedron Lett. 1999, 40, 213-216;
112. b) M. E. Jung, T. I. Lazarova, J. Org. Chem. 1999, 64, 2976-2977.
113. G. M. Sheldrick, SHELXTL 5.1, Bruker AXS Inc., Madison, WI (USA), 1997.
114. CrystalStructure 3.8: Crystal Structure Analysis Package, Rigaku and Rigaku/MSC, The Woodlands, TX (USA), 2000-2006.